Kintampo Health Research Centre, Ghana   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Kintampo Ghana (1994)

Organization Overview

First Clinical Trial
2000
NCT00857077
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Kintampo Health Research Centre, Ghana

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Ancylostomiasis (Phase 4)

Communicable Diseases (Phase 4)

Hookworm Infections (Phase 4)

Infections (Phase 4)

Malaria (Phase 4)

Malnutrition (Phase 3)

Maternal Death (Phase 3)

Night Blindness (Phase 3)

Vitamin A Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 12